You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy
|
---|---|
Published in |
Orphanet Journal of Rare Diseases, June 2022
|
DOI | 10.1186/s13023-022-02371-0 |
Pubmed ID | |
Authors |
Panagis Galiatsatos, Cheri Wilson, Jaime O’Brien, Anna J. Gong, Dylan Angiolillo, James Johnson, Carlie Myers, Sara Strout, Stephen Mathai, Gina Robinson, Nicholas R. Rowan, Clifford R. Weiss |
X Demographics
The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 9 | 47% |
Canada | 1 | 5% |
India | 1 | 5% |
Unknown | 8 | 42% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 13 | 68% |
Scientists | 3 | 16% |
Practitioners (doctors, other healthcare professionals) | 3 | 16% |
Mendeley readers
The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 13 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 23% |
Student > Master | 2 | 15% |
Student > Bachelor | 1 | 8% |
Student > Ph. D. Student | 1 | 8% |
Unknown | 6 | 46% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 2 | 15% |
Medicine and Dentistry | 2 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 8% |
Neuroscience | 1 | 8% |
Unspecified | 1 | 8% |
Other | 0 | 0% |
Unknown | 6 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2023.
All research outputs
#728,809
of 25,394,764 outputs
Outputs from Orphanet Journal of Rare Diseases
#65
of 3,110 outputs
Outputs of similar age
#18,012
of 444,560 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#4
of 106 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,110 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,560 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 106 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.